Dr. Adrienne Rivlin on future trends in Life Sciences | KPMG | UK

Dr. Adrienne Rivlin on future trends in Life Sciences

Dr. Adrienne Rivlin on future trends in Life Sciences

This series is one of the initiatives that demonstrates KPMG’s commitment to the development, advancement and leadership of women.

1000

Director, Head of Healthcare and Life Sciences Strategy, UK

KPMG in the UK

Contact

Also on KPMG.com

Dr. Adrienne Rivlin highlights three important trends in the life sciences industry.
  1. Advent of personalised medicine
  2. Collaboration and convergence within and across the sector
  3. The strong focus on preventative medicine

Connect with us

 

Request for proposal

 

Submit